Limerston Capital makes life sciences acquisition
Limerston Capital has acquired Concept Life Sciences, a leading integrated drug discovery, development and manufacturing organisation, in a carve-out from Spectris plc, through its new fund Limerston Capital Partners II, LP. The acquisition is Limerston’s fourth platform deal in the life sciences space. The firm targets UK businesses with EBITDA
